Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dabrafenib, an inhibitor of RIP3 kinase-dependent necroptosis, reduces ischemic brain injury
Hsiao‐Huei Chen, ShellyA Cruz, Zhaohong Qin, et al.
Neural Regeneration Research (2018) Vol. 13, Iss. 2, pp. 252-252
Open Access | Times Cited: 65

Showing 26-50 of 65 citing articles:

Role of Necroptosis in Intervertebral Disc Degeneration
Abdul Khaleque, Jae Hoon Kim, Byung-Jun Hwang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15292-15292
Open Access | Times Cited: 14
The Role of Necroptosis in Cerebral Ischemic Stroke
Qingsong Wang, Fan Yang, Kun Duo, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 7, pp. 3882-3898
Closed Access | Times Cited: 14
Lytic Cell Death Mechanisms in Human Respiratory Syncytial Virus-Infected Macrophages: Roles of Pyroptosis and Necroptosis
Lori Bedient, Swechha M. Pokharel, Kim Chiok, et al.
Viruses (2020) Vol. 12, Iss. 9, pp. 932-932
Open Access | Times Cited: 38
The Role of RIPK1 and RIPK3 in Cardiovascular Disease
Elise DeRoo, Ting Zhou, Bo Liu
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8174-8174
Open Access | Times Cited: 36
RSK3 mediates necroptosis by regulating phosphorylation of RIP3 in rat retinal ganglion cells
Mi Wang, Hao Wan, Shuchao Wang, et al.
Journal of Anatomy (2020) Vol. 237, Iss. 1, pp. 29-47
Open Access | Times Cited: 33
Understanding necroptosis and its therapeutic target for intervertebral disc degeneration
Zheng Wang, Xinli Hu, Wei Wang, et al.
International Immunopharmacology (2023) Vol. 121, pp. 110400-110400
Closed Access | Times Cited: 12
Novel, non-conventional pathways of necroptosis in the heart and other organs: Molecular mechanisms, regulation and inter-organelle interplay
Csaba Horváth, Izabela Jarabicová, Branislav Kura, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2023) Vol. 1870, Iss. 7, pp. 119534-119534
Open Access | Times Cited: 12
Inhibition of an Alzheimer’s disease–associated form of necroptosis rescues neuronal death in mouse models
Marta J. Koper, Sebastiaan Moonen, Alicja Ronisz, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 771
Closed Access | Times Cited: 4
Advances in the Study of Necroptosis in Vascular Dementia: Focus on Blood–Brain Barrier and Neuroinflammation
Yuemin Qiu, Lin Cheng, Yinyi Xiong, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 2
Open Access
MLKL as an emerging machinery for modulating organelle dynamics: regulatory mechanisms, pathophysiological significance, and targeted therapeutics
Yang Wang, Wei Wei, Yu Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Necroptosis: a significant and promising target for intervention of cardiovascular disease
Yanwei Ji, Xinyu Wen, He-peng Tang, et al.
Biochemical Pharmacology (2025), pp. 116951-116951
Closed Access
RIP3/MLKL-mediated neuronal necroptosis induced by methamphetamine at 39°C
Jie Yan, Kun Xiong, Limin Guo, et al.
Neural Regeneration Research (2019) Vol. 15, Iss. 5, pp. 865-865
Open Access | Times Cited: 32
RIPK3 blockade attenuates tubulointerstitial fibrosis in a mouse model of diabetic nephropathy
Ying Shi, Chunling Huang, Yongli Zhao, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 32
Necroptosis is one of the modalities of cell death accompanying ischemic brain stroke: from pathogenesis to therapeutic possibilities
Valentina Hribljan, Damir Lisjak, Dražen Juraj Petrović, et al.
Croatian Medical Journal (2019) Vol. 60, Iss. 2, pp. 121-126
Open Access | Times Cited: 31
Therapeutic potential of a TrkB agonistic antibody for ischemic brain injury
Fang Han, Xiao-Ming Guan, Wei Guo, et al.
Neurobiology of Disease (2019) Vol. 127, pp. 570-581
Closed Access | Times Cited: 30
No Time to Die: How Kidney Cancer Evades Cell Death
Carlo Ganini, Manuela Montanaro, Manuel Scimeca, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6198-6198
Open Access | Times Cited: 17
FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders
Austin Lui, Jordan Vanleuven, David Perekopskiy, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1546-1546
Open Access | Times Cited: 16
Genetic inhibition of RIPK3 ameliorates functional outcome in controlled cortical impact independent of necroptosis
Limin Wu, Joon Yong Chung, Tian Cao, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 11
Open Access | Times Cited: 23
Antioxidant and food additive BHA prevents TNF cytotoxicity by acting as a direct RIPK1 inhibitor
Tom Delanghe, Jon Huyghe, Seungheon Lee, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 7
Open Access | Times Cited: 22
Serum and cerebrospinal fluid tau protein level as biomarkers for evaluating acute spinal cord injury severity and motor function outcome
Jianfeng Zhong, Donglin Wang, Ying Tang, et al.
Neural Regeneration Research (2019) Vol. 14, Iss. 5, pp. 896-896
Open Access | Times Cited: 24
RIPK3 blockade attenuates kidney fibrosis in a folic acid model of renal injury
Ying Shi, Chunling Huang, Hao Yi, et al.
The FASEB Journal (2020) Vol. 34, Iss. 8, pp. 10286-10298
Closed Access | Times Cited: 23
Cpd-42 protects against calcium oxalate nephrocalcinosis-induced renal injury and inflammation by targeting RIPK3-mediated necroptosis
Bingbing Hou, Mingming Liu, Yang Chen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
B-RAFV600E Inhibitor Dabrafenib Attenuates RIPK3-Mediated Necroptosis and Promotes Functional Recovery after Spinal Cord Injury
Takehiro Sugaya, Haruo Kanno, M Matsuda, et al.
Cells (2019) Vol. 8, Iss. 12, pp. 1582-1582
Open Access | Times Cited: 20
Ring closure strategy leads to potent RIPK3 inhibitors
S. C. Wu, Xu Chen, Kaijiang Xia, et al.
European Journal of Medicinal Chemistry (2021) Vol. 217, pp. 113327-113327
Closed Access | Times Cited: 17
Necroptosis: A new target for prevention of osteoporosis
Xinli Hu, Zheng Wang, Chao Kong, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 11

Scroll to top